{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:30:17Z","timestamp":1794267017594,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972689"],"award-info":[{"award-number":["81972689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232102"],"award-info":[{"award-number":["7232102"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002888","name":"Beijing Municipal Commission of Education","doi-asserted-by":"publisher","award":["KZ202210005010"],"award-info":[{"award-number":["KZ202210005010"]}],"id":[{"id":"10.13039\/501100002888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nonalcoholic fatty liver disease (NAFLD), a major cause of chronic liver disorders, has become a serious public health issue. Although the Smad4 signaling pathway has been implicated in the progression of NAFLD, the specific role of Smad4 in hepatocytes in NAFLD pathogenesis remains unclear. Hepatocyte-specific knockout Smad4 mice (Alb\n                    <jats:sup>Smad4\u2212\/\u2212<\/jats:sup>\n                    ) were first constructed using the Cre-Loxp recombinant system to establish a high-fat diet induced NAFLD model. The role of Smad4 in the occurrence and development of NAFLD was determined by monitoring the body weight of mice, detecting triglycerides and free fatty acids in serum and liver tissue homogenates, staining the tissue sections to observe the accumulation of liver fat, and RT-qPCR detecting the expression of genes related to lipogenesis, fatty acid intake, and fatty acid \u03b2 oxidation. The molecular mechanism of Smad4 in hepatocytes affecting NAFLD was therefore investigated through combining in vitro and in vivo experiments. Smad4 deficiency in hepatocytes mitigated NAFLD progression and decreased inflammatory cell infiltration. Moreover, Smad4 deficiency inhibited CXCL1 secretion by suppressing the activation of the ASK1\/P38\/JNK signaling pathway. Furthermore, targeting CXCL1 using CXCR2 inhibitors diminished hepatocyte lipogenesis and inhibited the polarization of M1-type macrophages. Collectively, these results suggested that Smad4 plays a vital role in exacerbating NAFLD and may be a promising candidate for anti-NAFLD therapy.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07376-8","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:38:45Z","timestamp":1738319925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanxuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-8893","authenticated-orcid":false,"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"7376_CR1","doi-asserted-by":"crossref","unstructured":"Azzimato V, Jager J, Chen P, Morgantini C, Levi L, Barreby E, et al. Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance. Sci Transl Med. 2020;12:eaaw9709.","DOI":"10.1126\/scitranslmed.aaw9709"},{"key":"7376_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7376_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"7376_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69:1691\u2013705.","journal-title":"Gut"},{"key":"7376_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22:63.","journal-title":"BMC Endocr Disord"},{"key":"7376_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1172\/JCI200422422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Investig. 2004;114:147\u201352.","journal-title":"J Clin Investig"},{"key":"7376_CR7","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2337\/db07-1383","volume":"57","author":"M Bell","year":"2008","unstructured":"Bell M, Wang H, Chen H, McLenithan JC, Gong DW, Yang RZ, et al. Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes. 2008;57:2037\u201345.","journal-title":"Diabetes"},{"key":"7376_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","volume":"5","author":"DG Tiniakos","year":"2010","unstructured":"Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010;5:145\u201371.","journal-title":"Annu Rev Pathol"},{"key":"7376_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 2016;150:1769\u201377.","journal-title":"Gastroenterology"},{"key":"7376_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.freeradbiomed.2012.05.012","volume":"53","author":"Q Liu","year":"2012","unstructured":"Liu Q, Rehman H, Krishnasamy Y, Ramshesh VK, Theruvath TP, Chavin KD, et al. Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers. Free Radic Biol Med. 2012;53:250\u20139.","journal-title":"Free Radic Biol Med"},{"key":"7376_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/j.gastro.2016.08.024","volume":"151","author":"BA David","year":"2016","unstructured":"David BA, Rezende RM, Antunes MM, Santos MM, Freitas Lopes MA, Diniz AB, et al. Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice. Gastroenterology. 2016;151:1176\u201391.","journal-title":"Gastroenterology"},{"key":"7376_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10321","volume":"7","author":"CL Scott","year":"2016","unstructured":"Scott CL, Zheng F, De Baetselier P, Martens L, Saeys Y, De Prijck S, et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. 2016;7:10321.","journal-title":"Nat Commun"},{"key":"7376_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2337\/db09-0016","volume":"59","author":"W Huang","year":"2010","unstructured":"Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, Dube JJ, et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes. 2010;59:347\u201357.","journal-title":"Diabetes"},{"key":"7376_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbrc.2009.05.070","volume":"385","author":"AM Neyrinck","year":"2009","unstructured":"Neyrinck AM, Cani PD, Dewulf EM, De Backer F, Bindels LB, Delzenne NM. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem Biophys Res Commun. 2009;385:351\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"7376_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cphy.c120026","volume":"3","author":"LJ Dixon","year":"2013","unstructured":"Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol. 2013;3:785\u201397.","journal-title":"Compr Physiol"},{"key":"7376_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.22470","volume":"48","author":"I Hritz","year":"2008","unstructured":"Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 2008;48:1224\u201331.","journal-title":"Hepatology"},{"key":"7376_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 2011;54:133\u201344.","journal-title":"Hepatology"},{"key":"7376_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.26607","volume":"59","author":"J Wan","year":"2014","unstructured":"Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2014;59:130\u201342.","journal-title":"Hepatology"},{"key":"7376_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.23230","volume":"14","author":"M Zhao","year":"2018","unstructured":"Zhao M, Mishra L, Deng CX. The role of TGF-\u03b2\/SMAD4 signaling in cancer. Int J Biol Sci. 2018;14:111\u201323.","journal-title":"Int J Biol Sci"},{"key":"7376_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/1751-2980.12599","volume":"19","author":"G Qin","year":"2018","unstructured":"Qin G, Wang GZ, Guo DD, Bai RX, Wang M, Du SY. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression. J Dig Dis. 2018;19:301\u201313.","journal-title":"J Dig Dis"},{"key":"7376_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jclinpath-2018-205095","volume":"71","author":"AJ McCarthy","year":"2018","unstructured":"McCarthy AJ, Chetty R. Smad4\/DPC4. J Clin Pathol. 2018;71:661\u20134.","journal-title":"J Clin Pathol"},{"key":"7376_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.molcel.2004.07.011","volume":"15","author":"J Greenwald","year":"2004","unstructured":"Greenwald J, Vega ME, Allendorph GP, Fischer WH, Vale W, Choe S. A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. Mol Cell. 2004;15:485\u20139.","journal-title":"Mol Cell"},{"key":"7376_CR23","doi-asserted-by":"crossref","unstructured":"Matboli M, Gadallah SH, Rashed WM, Hasanin AH, Essawy N, Ghanem HM, et al. mRNA-miRNA-lncRNA regulatory network in nonalcoholic fatty liver disease. Int J Mol Sci. 2021;22:6770.","DOI":"10.3390\/ijms22136770"},{"key":"7376_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27353-x","volume":"13","author":"N Salah","year":"2023","unstructured":"Salah N, Eissa S, Mansour A, El Magd NMA, Hasanin AH, El Mahdy MM, et al. Evaluation of the role of kefir in management of non-alcoholic steatohepatitis rat model via modulation of NASH linked mRNA-miRNA panel. Sci Rep. 2023;13:236.","journal-title":"Sci Rep"},{"key":"7376_CR25","first-page":"221","volume":"123","author":"HY Li","year":"2015","unstructured":"Li HY, Oh YS, Lee YJ, Lee EK, Jung HS, Jun HS. Amelioration of high fat diet-induced glucose intolerance by blockade of Smad4 in pancreatic beta-cells. Exp Clin Endocrinol Diab. 2015;123:221\u20136.","journal-title":"Exp Clin Endocrinol Diab"},{"key":"7376_CR26","doi-asserted-by":"crossref","unstructured":"Wei M, Yan X, Xin X, Chen H, Hou L, Zhang J. Hepatocyte-specific smad4 deficiency alleviates liver fibrosis via the p38\/p65 pathway. Int J Mol Sci. 2022;23:11696.","DOI":"10.3390\/ijms231911696"},{"key":"7376_CR27","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3389\/fimmu.2020.01802","volume":"11","author":"X Pan","year":"2020","unstructured":"Pan X, Chiwanda Kaminga A, Liu A, Wen SW, Chen J, Luo J. Chemokines in non-alcoholic fatty liver disease: a systematic review and network meta-analysis. Front Immunol. 2020;11:1802.","journal-title":"Front Immunol"},{"key":"7376_CR28","first-page":"276","volume":"7","author":"J Feng","year":"2021","unstructured":"Feng J, Wei T, Cui X, Wei R, Hong T. Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis. Chronic Dis Transl Med. 2021;7:276\u201386.","journal-title":"Chronic Dis Transl Med"},{"key":"7376_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/aps.2013.182","volume":"35","author":"HM Lo","year":"2014","unstructured":"Lo HM, Lai TH, Li CH, Wu WB. TNF-\u03b1 induces CXCL1 chemokine expression and release in human vascular endothelial cells in vitro via two distinct signaling pathways. Acta Pharm Sin. 2014;35:339\u201350.","journal-title":"Acta Pharm Sin"},{"key":"7376_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep44612","volume":"7","author":"W Luo","year":"2017","unstructured":"Luo W, Xu Q, Wang Q, Wu H, Hua J. Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep. 2017;7:44612.","journal-title":"Sci Rep"},{"key":"7376_CR31","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/hep4.1892","volume":"6","author":"J Zhao","year":"2022","unstructured":"Zhao J, Hu L, Gui W, Xiao L, Wang W, Xia J, et al. Hepatocyte TGF-\u03b2 signaling inhibiting WAT browning to promote NAFLD and obesity is associated with let-7b-5p. Hepatol Commun. 2022;6:1301\u201321.","journal-title":"Hepatol Commun"},{"key":"7376_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12072-017-9841-y","volume":"12","author":"P Chen","year":"2018","unstructured":"Chen P, Luo Q, Huang C, Gao Q, Li L, Chen J, et al. Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. Hepatol Int. 2018;12:26\u201336.","journal-title":"Hepatol Int"},{"key":"7376_CR33","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2013.01.056","volume":"144","author":"L Yang","year":"2013","unstructured":"Yang L, Inokuchi S, Roh YS, Song J, Loomba R, Park EJ, et al. Transforming growth factor-\u03b2 signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology. 2013;144:1042\u20131054.","journal-title":"Gastroenterology"},{"key":"7376_CR34","doi-asserted-by":"crossref","unstructured":"Kundu A, Dey P, Park JH, Kim IS, Kwack SJ, Kim HS. EX-527 prevents the progression of high-fat diet-induced hepatic steatosis and fibrosis by upregulating SIRT4 in Zucker rats. Cells 2020; 9:1101.","DOI":"10.3390\/cells9051101"},{"key":"7376_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344\u201353.","journal-title":"Hepatology"},{"key":"7376_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49:197\u2013211.","journal-title":"Drug Metab Rev"},{"key":"7376_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S Kumar","year":"2021","unstructured":"Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176:113869.","journal-title":"Adv Drug Deliv Rev"},{"key":"7376_CR38","doi-asserted-by":"crossref","unstructured":"Korbecki J, G\u0105ssowska-Dobrowolska M, W\u00f3jcik J, Szatkowska I, Barczak K, Chlubek M, et al. The importance of CXCL1 in physiology and noncancerous diseases of bone, bone marrow, muscle and the nervous system. Int J Mol Sci. 2022;23:4205.","DOI":"10.3390\/ijms23084205"},{"key":"7376_CR39","doi-asserted-by":"crossref","unstructured":"Korbecki J, Barczak K, Gutowska I, Chlubek D, Baranowska-Bosiacka I. CXCL1: gene, promoter, regulation of expression, mRNA stability, regulation of activity in the intercellular space. Int J Mol Sci. 2022;23:792.","DOI":"10.3390\/ijms23020792"},{"key":"7376_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/hep.27921","volume":"62","author":"B Chang","year":"2015","unstructured":"Chang B, Xu MJ, Zhou Z, Cai Y, Li M, Wang W, et al. Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1. Hepatology. 2015;62:1070\u201385.","journal-title":"Hepatology"},{"key":"7376_CR41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1159\/000366344","volume":"34","author":"JM Shieh","year":"2014","unstructured":"Shieh JM, Tsai YJ, Tsou CJ, Wu WB. CXCL1 regulation in human pulmonary epithelial cells by tumor necrosis factor. Cell Physiol Biochem. 2014;34:1373\u201384.","journal-title":"Cell Physiol Biochem"},{"key":"7376_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341\u201355.","journal-title":"Cell"},{"key":"7376_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867260","volume":"13","author":"M Cutolo","year":"2022","unstructured":"Cutolo M, Campitiello R, Gotelli E, Soldano S. The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis. Front Immunol. 2022;13:867260.","journal-title":"Front Immunol"},{"key":"7376_CR44","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1053\/j.gastro.2009.12.041","volume":"138","author":"MM Hunter","year":"2010","unstructured":"Hunter MM, Wang A, Parhar KS, Johnston MJ, Van Rooijen N, Beck PL, et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology. 2010;138:1395\u2013405.","journal-title":"Gastroenterology"},{"key":"7376_CR45","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1096\/fj.11-189472","volume":"25","author":"N Lanthier","year":"2011","unstructured":"Lanthier N, Molendi-Coste O, Cani PD, van, Rooijen N, Horsmans Y, et al. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J. 2011;25:4301\u201311.","journal-title":"FASEB J"},{"key":"7376_CR46","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147:577\u201394.e571.","journal-title":"Gastroenterology"},{"key":"7376_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139:323\u201334.e327.","journal-title":"Gastroenterology"},{"key":"7376_CR48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hep.23337","volume":"51","author":"R Stienstra","year":"2010","unstructured":"Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology. 2010;51:511\u201322.","journal-title":"Hepatology"},{"key":"7376_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/neurintsurg-2016-012911","volume":"10","author":"KW Nowicki","year":"2018","unstructured":"Nowicki KW, Hosaka K, Walch FJ, Scott EW, Hoh BL. M1 macrophages are required for murine cerebral aneurysm formation. J Neurointerv Surg. 2018;10:93\u201397.","journal-title":"J Neurointerv Surg"},{"key":"7376_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/jbc.274.1.305","volume":"274","author":"C Postic","year":"1999","unstructured":"Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274:305\u201315.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07376-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07376-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07376-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:40:02Z","timestamp":1738320002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07376-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7376"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07376-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4507474\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal studies were performed after approval by the Institutional Laboratory Animal Care and Use Committee of the Institute of Biophysics, Chinese Academy of Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"58"}}